MannKind Corporation Proposes Production of Inhalable Insulin in Connecticut FTZ 76-Bridgeport

Summary

MannKind Corporation has submitted a notification to the U.S. Foreign-Trade Zone (FTZ) 76-Bridgeport, Connecticut, for proposed production of its inhalable insulin product, in Danbury, Connecticut.